Axsome Therapeutics Inc (NAS:AXSM)
$ 93.35 0 (0%) Market Cap: 4.48 Bil Enterprise Value: 4.36 Bil PE Ratio: 0 PB Ratio: 43.42 GF Score: 39/100

Axsome Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) Transcript

Jul 15, 2021 / 01:00PM GMT
Release Date Price: $56.77 (-0.09%)
Myles Minter
William Blair - Analyst

Good morning and welcome back to the William Blair Biotech Focus Conference for 2021. It's the second day after a jampacked full immuno-oncology day yesterday. My name is Myles Minter. I'm the Senior Biotech Analyst here at the firm covering neurosciences and RNA-targeted therapeutics. And it's my absolute pleasure to welcome Herriot Tabuteau, who is on the line with me today, CEO of Axsome Therapeutics, to discuss this fireside chat.

Before we get started, I do need to point you to disclosures that are available on WilliamBlair.com. And secondly, at the bottom of your screen, you can see a function to submit Q&A. I will do the best I can to get through those, but please submit them as you'd like throughout the chat.

So with that, Herriot, thanks for joining us again. Always great to chat. Just get the formalities out of the way maybe just for the benefit of our listeners, you can provide a brief overview of the Company and where it stands today.

Herriot Tabuteau
Axsome Therapeutics, Inc. - CEO

Sure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot